Change Language
OSIMERT(Osimetirib 80mg)
OSIMERT(Osimetirib 80mg)
OSIMERT(Osimetirib 80mg)
OSIMERT(Osimetirib 80mg)
OSIMERT(Osimetirib 80mg)
OSIMERT(Osimetirib 80mg)

OSIMERT(Osimetirib 80mg)

Price 10200.0 INR/ Bottle

MOQ : 1 Bottle

OSIMERT(Osimetirib 80mg) Specification

  • Drug Type
  • General Medicines
  • Physical Form
  • Tablets
  • Recommended For
  • Doctor
  • Dosage Guidelines
  • As per Instructions
  • Suitable For
  • Adults
  • Storage Instructions
  • Cool & Dry Place
 

OSIMERT(Osimetirib 80mg) Trade Information

  • Minimum Order Quantity
  • 1 Bottle
  • Payment Terms
  • [, ]
  • Delivery Time
  • 5-10 Days
  • Main Domestic Market
  • [, ]
 

About OSIMERT(Osimetirib 80mg)

Osimert 80 mg is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.Side Effects of Osimert 80 mgCommon side effects are Interstitial Lung Disease or Pneumonitis, QTc Interval Prolongation, Cardiomyopathy, KeratitisPregnancy & LactationUse in Pregnancy: There are no or limited amount of data from the use of Osimert 80 mg in pregnant women. Studies in animals have shown reproductive toxicity. Based on its mechanism of action and preclinical data, Osimert 80 mg may cause foetal harm when administered to a pregnant woman. Administration of Osimert 80 mg to pregnant rats was associated with embryolethality, reduced foetal growth and neonatal death at exposures similar to what is expected in humans. Osimert 80 mg is not recommended during pregnancy and in women of childbearing potential not using contraception.Use in Lactation: It is not known whether Osimert 80 mg or its metabolites are excreted in human milk. Administration to rats during gestation and early lactation was associated with adverse effects, including reduced growth rates and neonatal death. There is insufficient information on the excretion of Osimert 80 mg or its metabolites in animal milk. A risk to the suckling child cannot be excluded. Breast-feeding should discontinue during treatment with Osimert 80 mg.Fertility: There are no data on the effect of Osimert 80 mg on human fertility. Results from animal studies have shown that Osimert 80 mg has effects on male and female reproductive organs and could impair fertility
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Tablets Category

Viraday Tablets (Cipla)

Viraday Tablets (Cipla)

Price 3000 INR / Rod

Minimum Order Quantity : 10

Storage Instructions : Store in a cool dry place away from light and moisture

Dosage Guidelines : Take on an empty stomach; preferably at bedtime to reduce side effects

Drug Type : Other, Antiretroviral

Salt Composition : Efavirenz Emtricitabine and Tenofovir Disoproxil Fumarate

Tenolame Tablets

Tenolame Tablets

Price 100 INR / Tablet

Minimum Order Quantity : 100

Storage Instructions : Store in a cool dry place below 25C. Protect from light and moisture.

Dosage Guidelines : Take with or without food at a consistent time each day

Drug Type : Other, Pharmaceutical

Salt Composition : Tenofovir Disoproxil Fumarate Lamivudine

Tencfovir Disoprocil Fumarate Lamivudine Efavirenz Tables Ip(Emcure)

Tencfovir Disoprocil Fumarate Lamivudine Efavirenz Tables Ip(Emcure)

Price 3455 INR / Tablet

Minimum Order Quantity : 10

Storage Instructions : Store below 30C in a dry place protected from light and moisture.

Dosage Guidelines : Take one tablet daily on an empty stomach or as directed by a physician.

Drug Type : Other, Antiviral Drug

Salt Composition : Tenofovir Disoproxil Fumarate Lamivudine Efavirenz

trastuzumab emtansine 100 mg

trastuzumab emtansine 100 mg

Price 80000 INR / Unit

Minimum Order Quantity : 10 Units

Storage Instructions : Store in a refrigerator at 2C to 8C do not freeze protect from light

Dosage Guidelines : Administered via intravenous infusion every 3 weeks as per oncologists recommendation

Drug Type : Biologic Drug, Other

Salt Composition : Trastuzumab linked to DM1 (a derivative of maytansine)



Back to top